FIELD: medicine.
SUBSTANCE: method involves determining vasomotor function of endothelium and ET-1 level. The ET-1 value being equal to18.88±2.14 pkmole/l, endothelium of dependent vasodilation being equal to 4.67±1.96%, endothelium of independent vasodilation being equal to 11.7±0.99% for patients younger than 60 years and ET-1 equal to 5.9±1.30 pkmole/l, endothelium of dependent vasodilation being equal to 7.15±0.88%, endothelium of independent vasodilation being equal to 9.04±1.31% for patients elder than 60 years, cardiac ischemia disease development is predicted to occur.
EFFECT: high reliability of prognosis.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING ARTERIAL HYPERTENSION VARIANT IN ELDERLY AND SENILE PATIENTS | 2003 |
|
RU2266702C2 |
| METHOD FOR THERAPY EFFECTIVENESS PREDICTION FOR PATIENTS WITH CORONARY ARTERY DISEASE 12 MONTHS AFTER ACUTE CORONARY SYNDROME | 2016 |
|
RU2613298C1 |
| METHOD FOR EVALUATING ENDOTHELIAL FUNCTION IN A YOUNG PATIENT | 2006 |
|
RU2321862C1 |
| METHOD FOR SELECTING PATIENTS WITH DIABETES MELLITUS OF TYPE 2 IN RISK GROUP OF DEVELOPING ENDOTHELIAL DYSFUNCTION | 2015 |
|
RU2607187C1 |
| METHOD FOR DETERMINING RISK OF CORONARY ARTERY ATHEROSCLEROSIS IN PATIENTS SUFFERING FROM DIABETES MELLITUS ACCOMPANIED BY CARDIOVASCULAR DISORDERS | 2013 |
|
RU2532521C1 |
| METHOD OF PREDICTING SPASM OF CORONARY ARTERIES IN PATIENTS WITH ISCHEMIC HEART DISEASE DURING TRANSCUTANEOUS SURGERY | 2010 |
|
RU2446734C1 |
| METHOD FOR PREDICTING CARDIOVASCULAR COMPLICATIONS WITHIN 12 MONTHS AFTER ELECTIVE ENDOVASCULAR MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2020 |
|
RU2749485C1 |
| METHOD FOR DETERMINING ENDOTHELIUM-INDEPENDENT ARTERY REACTIVITY BY ESTIMATING PULSE WAVE PROPAGATION SPEED CHANGES IN NITROGLYCERIN TEST | 2005 |
|
RU2308877C2 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING ISCHEMIC HEART DISEASE IN MEN WITH TYPE 2 DIABETES MELLITUS BASED ON GENOTYPING POLYMORPHISM rs16931366 OF ITPR2 GENE | 2024 |
|
RU2821764C1 |
| METHOD FOR DETERMINING THE DEGREE OF RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN COVID-19 | 2021 |
|
RU2768575C1 |
